Pharmacological Comparisons Between Cannabidiol and KLS-13019

Evidence for cannabis and cannabinoids for epilepsy: a systematic review of controlled and observational evidence

(2018) Emily Stockings et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Pharmacotherapeutic considerations for use of cannabinoids to relieve pain in patients with malignant diseases

(2018) Marija Darkovska-Serafimovska et al.   Journal of Pain Research

Cannabidiol disrupts the consolidation of specific and generalized fear memories via dorsal hippocampus CB 1 and CB 2 receptors

(2017) Cristina A.J. Stern et al.   NEUROPHARMACOLOGY

Selective post-training time window for memory consolidation interference of cannabidiol into the prefrontal cortex: Reduced dopaminergic modulation and immediate gene expression in limbic circuits

(2017) Matheus Teixeira Rossignoli et al.   NEUROSCIENCE

A Systematic Review of the Effectiveness of Medical Cannabis for Psychiatric, Movement and Neurodegenerative Disorders

(2017) Keane Lim et al.   Clinical Psychopharmacology and Neuroscience

Cannabidiol Modulates Fear Memory Formation Through Interactions with Serotonergic Transmission in the Mesolimbic System

(2016) Christopher Norris et al.   NEUROPSYCHOPHARMACOLOGY

Discovery of KLS-13019, a Cannabidiol-Derived Neuroprotective Agent, with Improved Potency, Safety, and Permeability

(2016) William A. Kinney et al.   ACS Medicinal Chemistry Letters

GET73 Prevents Ethanol-Induced Neurotoxicity in Primary Cultures of Rat Hippocampal Neurons

(2015) Maria C. Tomasini et al.   ALCOHOL AND ALCOHOLISM

Molecular Targets of Cannabidiol in Neurological Disorders

(2015) Clementino Ibeas Bih et al.   Neurotherapeutics

Cannabidiol protects liver from binge alcohol-induced steatosis by mechanisms including inhibition of oxidative stress and increase in autophagy

(2014) Lili Yang et al.   FREE RADICAL BIOLOGY AND MEDICINE

Peroxisome proliferator-activated receptor-γ activation attenuates motor and cognition impairments induced by bile duct ligation in a rat model of hepatic cirrhosis

(2014) Iraj Aghaei et al.   PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: A role for A2A receptors

(2013) M. Mecha et al.   NEUROBIOLOGY OF DISEASE

Mechanisms of cannabidiol neuroprotection in hypoxic–ischemic newborn pigs: Role of 5HT1A and CB2 receptors

(2013) M. Ruth Pazos et al.   NEUROPHARMACOLOGY

Small Molecule Anticonvulsant Agents with Potent In Vitro Neuroprotection

(2012) Douglas E. Brenneman et al.   JOURNAL OF MOLECULAR NEUROSCIENCE

Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress

(2011) George W. Booz   FREE RADICAL BIOLOGY AND MEDICINE

Cannabidiol improves brain and liver function in a fulminant hepatic failure-induced model of hepatic encephalopathy in mice

(2010) Y Avraham et al.   BRITISH JOURNAL OF PHARMACOLOGY

CGP-37157 Inhibits the Sarcoplasmic Reticulum Ca2+ ATPase and Activates Ryanodine Receptor Channels in Striated Muscle

(2010) J. T. Neumann et al.   MOLECULAR PHARMACOLOGY

Cannabidiol Targets Mitochondria to Regulate Intracellular Ca2+ Levels

(2009) D. Ryan et al.   JOURNAL OF NEUROSCIENCE

The neuroprotective effect of cannabidiol in an in vitro model of newborn hypoxic–ischemic brain damage in mice is mediated by CB2 and adenosine receptors

(2009) A. Castillo et al.   NEUROBIOLOGY OF DISEASE

The Nonpsychotropic Cannabinoid Cannabidiol Modulates and Directly Activates Alpha-1 and Alpha-1-Beta Glycine Receptor Function

(2009) Jörg Ahrens et al.   PHARMACOLOGY